VANGUARD CAPITAL MANAGEMENT LLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 2100119 MALVERN, PA

Position in CRL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$552,380,190

New position

Shares Held

3,202,204

first reported quarter

Ownership

6.65%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

VANGUARD CAPITAL MANAGEMENT LLC holds $38,476,447,490 across 42 Diagnostics & Research names. CRL ranks #13 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TMO	Thermo Fisher Scientific Inc.	24,280,816	$11,934,749,488
2	DHR	Danaher Corp /De/	41,127,810	$7,797,832,776
3	IDXX	Idexx Laboratories Inc /De	5,182,507	$2,911,998,858
4	A	Agilent Technologies, Inc.	18,381,030	$2,095,069,799
5	WAT	Waters Corp /De/	6,378,775	$1,899,599,195
6	IQV	Iqvia Holdings Inc.	11,026,983	$1,880,541,680
7	MTD	Mettler Toledo International Inc/	1,321,854	$1,667,122,264
8	LH	Labcorp Holdings Inc.	5,376,120	$1,434,402,577

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$552,380,190	3,202,204	-11.9%	Shares	Defined	2026-05-15
2026-03-31	$626,929,860	3,634,376	—	Shares	Sole	2026-04-29
No filing history on record for this holder in this stock.